Emotion recognition and adverse childhood experiences in individuals at clinical high risk of psychosis

S Tognin; A Catalan; G Modinos; MJ Kempton; A Bilbao; B Nelson; C Pantelis; A Riecher-Rössler; R Bressan; N Barrantes-Vidal; MO Krebs; M Nordentoft; S Ruhrmann; G Sachs; BPF Rutten; J Van Os; L De Haan; M Van Der Gaag; P McGuire; LR Valmaggia

Journal article

Emotion recognition and adverse childhood experiences in individuals at clinical high risk of psychosis

S Tognin, A Catalan, G Modinos, MJ Kempton, A Bilbao, B Nelson, C Pantelis, A Riecher-Rössler, R Bressan, N Barrantes-Vidal, MO Krebs, M Nordentoft, S Ruhrmann, G Sachs, BPF Rutten, J Van Os, L De Haan, M Van Der Gaag, P McGuire, LR Valmaggia

Schizophrenia Bulletin | OXFORD UNIV PRESS | Published : 2020

DOI: 10.1093/schbul/sbz128

Abstract

Objective: To investigate the association between facial affect recognition (FAR) and type of adverse childhood experiences (ACEs) in a sample of clinical high risk (CHR) individuals and a matched sample of healthy controls (HCs). Methods: In total, 309 CHR individuals and 51 HC were recruited as part of an European Union-funded multicenter study (EU-GEI) and included in this work. During a 2-year follow-up period, 65 CHR participants made a transition to psychosis (CHR-T) and 279 did not (CHR-NT). FAR ability was measured using a computerized version of the Degraded Facial Affect Recognition (DFAR) task. ACEs were measured using the Childhood Experience of Care and Abuse Questionnaire, the ..

View full abstract

University of Melbourne Researchers

Barnaby Nelson Author

Christos Pantelis Author

Lucia Valmaggia Author

Related Projects (1)

CAN WE PREDICT PSYCHOSIS AND CAN IT BE PREVENTED?

It remains unclear what the causes of schizophrenia and other psychotic disorders are and what the most effective interventions are for prev..

Grants

Awarded by European Commission

Funding Acknowledgements

The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) Project is funded by grant agreement HEALTH-F2-2010-241909 (Project EU-GEI) from the European Community's Seventh Framework Programme. Additional support was provided by a Medical Research Council Fellowship to M. Kempton (grant MR/J008915/1). S. Tognin is supported by by a Brain and Behavior Young Investigator award (NARSAD YI, 24786) and by a Maudsley Charity Grant (1510). G. Modinos is supported by a Sir Henry Dale Fellowship, jointly funded by the Wellcome Trust and the Royal Society (#202397/Z/16/Z). B. Nelson was supported by an NHMRC Senior Research Fellowship (1137687). N. Barrantes-Vidal was supported by the Ministerio de Ciencia, Innovacion e Universidades (PSI2017-87512-C2-1-R) and the Generalitat de Catalunya (2017SGR1612 and ICREA Academia Award).